In summary, known ALCL driving factors, including CEBPB, nuclear factor κB (NF-κB), mitogen-activated protein kinase (MAPK), and STAT3, were suggested as upstream regulators targeting the affected hypo- and hypermethylated genes identified from our datasets (Figure S7). The gene discussed is CEBPB; the disease is anaplastic large cell lymphoma.